H. Hatano

发表

Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression

C. Yoder, R. Dewar, J. Metcalf, 2000, AIDS.

Virologic Characterization of HIV Type 1 With a Codon 70 Deletion in Reverse Transcriptase

D. Kuritzkes, H. Hatano, Zixin Hu, 2007, Journal of acquired immune deficiency syndromes.

Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia

Jeffrey N. Martin, D. Kuritzkes, H. Hatano, 2012, Antimicrobial Agents and Chemotherapy.

Reduction of HIV Persistence Following Transplantation in HIV‐Infected Kidney Transplant Recipients

H. Hatano, P. Stock, M. Busch, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunologic profiles distinguish aviremic HIV-infected adults

Jeffrey N. Martin, H. Hatano, F. Hecht, 2016, AIDS.

Reply to Karch et al.

H. Hatano, P. Bacchetti, S. Deeks, 2014, The Journal of infectious diseases.

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

M. Lederman, Jeffrey N. Martin, C. Meinert, 2014, PLoS pathogens.

A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals

H. Hatano, S. Lewin, E. Sinclair, 2017, Pathogens & immunity.

Structure and Function of Macrophage Scavenger Receptors

Haruki Nakamura, T. Kodama, Y. Yazaki, 1994 .

Post-Treatment Controllers: Role in HIV “Cure” Research

H. Hatano, S. Deeks, L. Cockerham, 2016, Current HIV/AIDS Reports.

Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers

Jeffrey N. Martin, H. Hatano, E. Sinclair, 2013, AIDS.

Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

H. Hatano, F. Hecht, J. McCune, 2013, The Journal of infectious diseases.

Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions.

H. Hatano, A. Khoruts, C. Reilly, 2015, The Journal of infectious diseases.

Immune activation and HIV persistence: considerations for novel therapeutic interventions

H. Hatano, 2013, Current opinion in HIV and AIDS.

Immunity Status Against Influenza A Subtype H7N9 and Other Avian Influenza Viruses in a High-Risk Group and the General Population in India

H. Hatano, P. Bacchetti, S. Deeks, 2014 .

Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes.

P. Rosenthal, H. Hatano, D. Havlir, 2010, Journal of virological methods.

Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.

Jeffrey N. Martin, H. Hatano, F. Hecht, 2013, The Journal of infectious diseases.

Induction of Fc and C3b receptors on rabbit corneal cells by herpes simplex virus.

H. Hatano, P. Minasi, J. Oh, 1988, Investigative ophthalmology & visual science.

Effect of neuraminidase on Fc and C3b receptors on rabbit corneal cells infected with herpes simplex virus.

H. Hatano, J. Oh, 1987, Current eye research.

Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.

Eoin Coakley, Rebecca Hoh, Peter Hunt, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy

Jeffrey N. Martin, C. Petropoulos, H. Hatano, 2010, Journal of acquired immune deficiency syndromes.

Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals

Jeffrey N. Martin, H. Hatano, E. Delwart, 2010, AIDS.

Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging

Steven G. Deeks, Frederick M. Hecht, Elizabeth Sinclair, 2014, PloS one.

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

Xin Geng, Peter W. Hunt, W. Greene, 2013, Nature.

Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy

Jeffrey N. Martin, H. Hatano, E. Delwart, 2008, Journal of Virology.

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

R. Siliciano, D. Richman, D. Kuritzkes, 2017, PLoS medicine.

Occurrence of etravirine/rilpivirine-specific resistance mutations selected by efavirenz and nevirapine in Kenyan patients with non-B HIV-1 subtypes failing antiretroviral therapy

H. Hatano, D. Havlir, E. Sinclair, 2014, AIDS.

Cell death bypyroptosis drives CD 4 T-cell depletion in HIV-1 infection

W. Greene, H. Hatano, G. Doitsh, 2013 .

Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency

H. Hatano, J. Wong, S. Deeks, 2018, PLoS pathogens.

C-banding study of chromosomes in Pacific abalone, Haliotis discus hannai (Archaeogastropoda : Haliotidae)

H. Hatano, K. Yamamori, S. Yamada, 1995 .

HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control

Steven G. Deeks, Elizabeth Sinclair, Jeffrey N. Martin, 2008, Journal of Virology.

Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers

Jeffrey N. Martin, H. Hatano, J. McCune, 2013, PLoS pathogens.

A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, PloS one.

Clinical outcomes and antiretroviral therapy in ‘elite’ controllers: a review of the literature

H. Hatano, T. Crowell, 2015, Journal of virus eradication.

Elite control of HIV: is this the right model for a functional cure?

H. Hatano, L. Cockerham, 2015, Trends in microbiology.

HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1

D. Kuritzkes, H. Hatano, Zixin Hu, 2006, Journal of Virology.

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Rebecca Hoh, Peter Bacchetti, Matthew C Strain, 2013, The Journal of infectious diseases.

A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response.

Jeffrey N. Martin, H. Hatano, J. McCune, 2011, The Journal of infectious diseases.

Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy.

P. Lemey, E. Boritz, H. Hatano, 2015, The Journal of infectious diseases.

Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay.

H. Hatano, S. Deeks, T. Liegler, 2020, Journal of acquired immune deficiency syndromes.

Gag p24 is a Marker of HIV Expression in Tissues and Correlates with Immune Response.

D. Hazuda, H. Hatano, A. Haase, 2021, Journal of Infectious Diseases.

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?

H. Hatano, R. Price, L. Hagberg, 2018, The Journal of infectious diseases.

Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites

E. Boritz, H. Hatano, F. Hecht, 2019, Journal of Virology.

Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy

C. Yoder, R. Davey, H. Hatano, 2000, AIDS.

Novel Approaches To Curing HIV

H. Hatano, 2012 .

The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting

H. Hatano, D. Havlir, E. Geng, 2017, Journal of acquired immune deficiency syndromes.

Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients

Jeffrey N. Martin, H. Hatano, P. Ganz, 2009, AIDS.

A Randomized Controlled Trial Assessing the Effects of Raltegravir Intensification on Endothelial Function in Treated HIV Infection

Jeffrey N. Martin, H. Hatano, E. Sinclair, 2012, Journal of acquired immune deficiency syndromes.

Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease

Jeffrey N. Martin, D. Glidden, H. Hatano, 2014, AIDS.

Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 “Deep” Sequencing

Jeffrey N. Martin, P. Harrigan, M. Wainberg, 2012, PLoS ONE.

Corrigendum: Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

W. Greene, H. Hatano, G. Doitsh, 2017, Nature.

Drug resistant HIV

H. Hatano, S. Deeks, 2007, BMJ : British Medical Journal.

Pyroptosis drives CD4 T-cell depletion in HIV-1 infection

W. Greene, H. Hatano, G. Doitsh, 2015 .

The impact of antiretroviral therapy duration on the HIV-1 infection of T-cells within anatomic sites

E. Boritz, H. Hatano, F. Hecht, 2019 .